Engineering Psychoplastogens: Toward a Safer Alternative for Treating Depression
Identification of psychoplastogenic isoDMT analogs is a concrete step forward in using psychedelics for treating patients who suffer from depression.
Identification of psychoplastogenic isoDMT analogs is a concrete step forward in using psychedelics for treating patients who suffer from depression.
This compound exhibits reduced cardiotoxicity, psychoplastogen characteristics, and potential therapeutic effects in animal models.
The MEQ is a self-report measure that provides insight into a key aspect of the psychedelic experience.
This study is the first of its kind to suggest that psilocybin enhances emotional empathy but does not affect moral behavior.
Researchers at the forefront of psychedelic science put forth their arguments in this important debate.
“Obviously, bureaucracy is not a human being. People have compassion. Bureaucracies don’t always have compassion.' -- Spencer Hawkswell
Psychedelic medicine continues to move forward, but minority communities are being left behind.
Interestingly, changes in migraine frequency were not correlated with the intensity of the acute psychotropic effects.
The characterization of methoxetamine, a ketamine analog, and how its action on the serotonin system sets it apart.
A recent study shows DMT reduces the cellular stress caused by a stroke and speeds up recovery time in rats. These findings highlight the expanding therapeutic potential of DMT regarding neurological disorders.
Psychedelic Science Review is working to bring cutting-edge science in the field of psychedelics to the public in the most accessible, thorough and accurate way possible. Join our communities on Facebook, Twitter, LinkedIn and Instagram and share our content with your network to help us bring scientifically-backed information about psychedelics to the world.